Skip to main content
. 2005 Jun;115(2):239–245. doi: 10.1111/j.1365-2567.2005.02135.x

Table 3. Per cent TCR-αβ+ CD8+ tetramer+ and per cent bulk TCR-αβ+ CD8+ (tetramer) in parentheses expressing each marker among five volunteers from the BMLF1 group1, 2.

Subject ID

Marker 01 07 08 09
CD27 81 (73) 83 (88) 64 (93) 95 (78)
CD28 26 (49) 24 (81) 35 (77) 92 (70)
CD45RA 13 (28) 20 (63) 90 (84) 2 (38)
CD62L 33 (47) 16 (59) 7 (44) 41 (67)
CD94 26 (19) 26 (6) 25 (3) 44 (11)
HLA-DR 34 (18) 27 (7) 32 (9) 19 (8)
Granzyme A 93 (74) 95 (51) 91 (31) 91 (48)
Perforin 42 (33) 26 (8) 16 (8) 24 (23)
CXCR3 25 (32) 71 (59) 55 (63) 81 (61)
CXCR4 6 (20) 13 (56) 35 (67) 2 (16)
CXCR5 2 (13) 3 (0) 8 (3) 1 (3)
CCR5 40 (33) 43 (22) 29 (7) 89 (27)
CCR6 2 (8) 6 (15) 1 (6) 4 (5)
CCR7 2 (18) 5 (68) 7 (59) 18 (53)
1

Per cent marker expression is derived from the number of marker-positive tetramer + events (upper right quadrant of plots in Figs 1 and 2) or tetramer (bulk CD8+ T cells) events (bottom right quadrant) divided by number of total tetramer+ or tetramer (bulk CD8+ T cells) events (upper or bottom right and left quadrants).

2

Markers shown in bold or underlined across the donor indicate that the mean per cent marker expression of the tetramer + CD8+ T cell is significantly lower (bold) or higher (underline) than that of the tetramer CD8+ T cell (bulk CD8+ T cells) with P < 0·05, determined by the paired Student's t-test. See the graphical representation of these values in Fig. 3